NASHVILLE, Tenn., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Symmetry Surgical Inc. (Nasdaq:SSRG) announced today financial results for the third quarter ended October 3, 2015.
Thomas J. Sullivan, President and Chief Executive Officer of Symmetry Surgical, stated, “We continued to forge ahead in our journey, delivering our third consecutive quarter of revenue growth in a challenging marketplace. Revenue highlights included year-over-year and sequential growth in the U.S., with mid-single digit volume growth, complemented by a partial quarter benefit from the acquisition of the assets of Vesocclude Medical. We generated $2.1 million in EBITDA, despite the impact of approximately $0.4 million for deal costs, currency conversion charges, and other one-time expenses. We are especially pleased with our Teammates’ ability to generate free cash flow at $5.3 million, well in excess of our EBITDA.”
Help employers find you! Check out all the jobs and post your resume.
